Non-Invasive Assessment of Liver Fibrosis Using Diffusion-Weighted MRI
Öz
Background/Aims: In this study, we aimed to evaluate the stage of liver fibrosis in patients with chronic hepatitis and cirrhosis due to HBV and HCV, with DWI-MRI instead of the liver biopsy, and to investigate whether ADC values can practically replace histological fibrosis staging.
Methods: We included 46 cases with diagnosis of confirmed chronic hepatitis whose Ishaac fibrosis scoring were performed and 11 cases were assesed as normal according to radiological and clinical data.The ADC value of liver fibrosis patients and healthy controls was compared. The correlation of ADC value and liver fibrosis staging was analyzed.
Results: The ADC values were demonstrated to be decreased with increasing fibrosis stage.Very high statistical significance was found between the mean liver ADC values (p<0.001). A high level of statistical significance was found between the normalized liver ADC values (0.001≤p<0.01).
Conclusion: DWI images have been among the routine sequences in many imaging centers, are being used extensively, and give good results in the staging of fibrosis. With further studies we can access to standardized values which can lead to more efficient results.
Anahtar Kelimeler
liver fibrosis, MRI, DWI, ADC
Etik Beyan
The Institutional Ethics Committee of İstanbul EAH approved this study Year 2017 , number 1114, and informed consent was obtained from all participants.
Kaynakça
- Friedman SL. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. Journal of Biological Chemistry. 2000; 275(4):2247-2250.
- Friedman SL. Mechanisms of disease: mechanisms of hepatic fibrosis and therapeutic implications. Nature clinical practice Gastroenterology & hepatology. 2004;1(2):98-105.
- Knodell RG, Ishak KG, Black WC, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology. 1981;1(5):431-435.
- Ishak K. Histological grading and staging of chronic hepatitis. J hepatol. 1995;22:696-699.
- Dufour J-F, Delellis R, Kaplan MM. Regression of hepatic fibrosis in hepatitis C with long-term interferon treatment. Digestive diseases and sciences. 1998;43:2573-2576.
- Malekzadeh R, Mohamadnejad M, Nasseri-Moghaddam S, et al. Reversibility of cirrhosis in autoimmune hepatitis. The American journal of medicine. 2004;117(2):125-129.
- Wanless IR, Nakashima E, Sherman M. Regression of human cirrhosis: morphologic features and the genesis of incomplete septal cirrhosis. Archives of pathology & laboratory medicine. 2000;124(11):1599-1607.
- Thampanitchawong P, Piratvisuth T. Liver biopsy:complications and risk factors. World J Gastroenterol. Aug 1999;5(4):301-304. doi:10.3748/wjg.v5.i4.301
- Regev A, Berho M, Jeffers LJ, et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. The American journal of gastroenterology. 2002;97(10):2614-2618.
- Koh DM, Collins DJ. Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol. Jun 2007;188(6):1622-35. doi:10.2214/ajr.06.1403